Drug Profile
Hydrocortisone/lidocaine - Citius Pharmaceuticals
Alternative Names: CITI-001; Hydro-LidoLatest Information Update: 27 Sep 2019
Price :
$50
*
At a glance
- Originator Citius Pharmaceuticals LLC
- Developer Citius Pharmaceuticals Inc
- Class Acetanilides; Anti-inflammatories; Antiallergics; Class Ib antiarrhythmics; Glucocorticoids; Local anaesthetics; Pregnenediones
- Mechanism of Action Glucocorticoid receptor agonists; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Haemorrhoids